Wallace Capital Management Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 829 filers reported holding NOVARTIS A G in Q1 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.

Quarter-by-quarter ownership
Wallace Capital Management Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2019$9,054,000
-5.8%
99,157
-0.9%
1.19%
-10.4%
Q1 2019$9,616,000
+12.7%
100,024
+0.6%
1.33%
+7.3%
Q4 2018$8,530,000
-0.5%
99,402
-0.1%
1.24%
+13.7%
Q3 2018$8,576,000
+15.2%
99,537
+1.0%
1.09%
+10.0%
Q2 2018$7,442,000
-3.6%
98,523
+3.2%
0.99%
-10.0%
Q1 2018$7,720,000
+8.9%
95,483
+13.0%
1.10%
+1.9%
Q4 2017$7,092,000
-1.4%
84,468
+0.9%
1.08%
-6.2%
Q3 2017$7,190,000
+9.1%
83,752
+6.1%
1.15%
+9.5%
Q2 2017$6,588,000
+15.8%
78,927
+3.0%
1.05%
+8.0%
Q1 2017$5,689,000
+6.4%
76,605
+4.4%
0.97%
+0.5%
Q4 2016$5,346,000
-7.9%
73,382
-0.2%
0.97%
-5.1%
Q3 2016$5,805,000
-1.8%
73,507
+2.6%
1.02%
+4.3%
Q2 2016$5,911,000
+21.9%
71,636
+7.0%
0.98%
+14.0%
Q1 2016$4,850,000
-12.5%
66,949
+4.0%
0.86%
-18.3%
Q4 2015$5,540,000
-4.7%
64,389
+1.9%
1.05%
-1.1%
Q3 2015$5,811,000
-1.8%
63,214
+5.1%
1.06%
+3.1%
Q2 2015$5,916,000
+0.8%
60,154
+1.1%
1.03%
-0.2%
Q1 2015$5,868,000
+12.7%
59,506
+5.8%
1.03%
+3.6%
Q4 2014$5,209,000
+4.5%
56,218
+6.2%
1.00%
-2.6%
Q3 2014$4,984,000
+7.3%
52,948
+3.2%
1.02%
+4.9%
Q2 2014$4,645,000
+11.6%
51,306
+4.8%
0.98%
+7.4%
Q1 2014$4,163,000
+8.9%
48,967
+2.9%
0.91%
+3.4%
Q4 2013$3,824,000
+8.4%
47,577
+3.4%
0.88%
-9.0%
Q3 2013$3,529,000
+10.8%
46,001
+2.1%
0.97%
+0.8%
Q2 2013$3,186,00045,0560.96%
Other shareholders
NOVARTIS A G shareholders Q1 2014
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders